首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

2058260

雷尼替丁市場：依活性成分濃度、劑型、給藥途徑、應用、通路及地區分類

Ranitidine Market, By Strength, By Form, By Route of Administration, By Application, By Distribution Channel, By Geography

出版日期: 2026年05月29日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

雷尼替丁市場預計在2026年達到4.844億美元，預計到2033年將達到5.49億美元。預計從2026年到2033年，其複合年成長率將達到1.8%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	4.844億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	1.80%	2033年市場規模預測：	5.49億美元

雷尼替丁是一種組織胺H2受體拮抗劑，可憑處方或非處方購買。雷尼替丁用於治療腸潰瘍和胃潰瘍、胃食道逆流（GERD）、糜爛性食道炎和柔林格症候群。胃潰瘍和胜肽類潰瘍會在胃壁或小腸上段形成開放性潰瘍。雷尼替丁有助於減少患者胃酸的過度分泌。一些增加胜肽類潰瘍風險的因素，例如使用止痛藥、某些藥物（如類固醇、小劑量阿斯匹靈以及選擇性血清素再回收抑制劑（SSRIs）與止痛藥的聯合用藥）、吸煙、過量飲酒、未得到有效控制的壓力以及食用辛辣食物，都會顯著增加患者發生潰瘍的可能性。

市場動態

由於全球胃食道逆流症 (GERD) 以及胃腸道潰瘍的盛行率不斷上升，預計雷尼替丁市場在預測期內將持續成長。例如，2014 年 6 月發表在《腸道》(Gut) 雜誌上的一項綜述研究估算了 2014 年全球人群中 GERD 的盛行率範圍。研究顯示，北美 GERD 的盛行率為 18%–28%，歐洲為 9%–26%，東亞為 3%–8%，中東為 9%–33%，澳洲為 12%，拉丁美洲為 23%。根據這些統計數據，北美和中東是 GERD 高發地區。

此外，雷尼替丁在抑制胃腸道潰瘍方面表現出優異的療效和耐受性，導致市場上雷尼替丁類藥物的採用率不斷提高。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
本研究根據以下參數對全球雷尼替丁市場的主要參與者進行了分析：公司概況、財務表現、產品系列、企業發展區域、分銷策略、主要發展、策略和未來計劃。
透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球雷尼替丁市場報告旨在為行業內的各種相關人員提供參考，包括投資者、供應商、雷尼替丁產品製造商、經銷商、新參與企業和金融分析師。
透過用於分析雷尼替丁市場的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第10章競爭格局

熱圖分析
市佔率分析
公司簡介
- GlaxoSmithKline plc
- Boehringer Ingelheim GmbH
- Strides Pharma Science Limited（StridesShasun）
- Tocris Bioscience（R & D Systems）
- Merck KGaA
- Sun Pharmaceutical Industries Limited

第11章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI2131

Ranitidine Market is estimated to be valued at USD 484.4 Mn in 2026 and is expected to reach USD 549.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 1.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 484.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	1.80%	2033 Value Projection:	USD 549.0 Mn

Ranitidine is a histamine type 2 (H2) receptor blocker drug available by prescription as well as over-the-counter (OTC). Ranitidine is used in treatment of intestinal & stomach ulcers, gastroesophageal reflux disease (GERD), and erosive esophagitis, and Zollinger-Ellison syndrome. Stomach ulcer or peptide ulcer causes open sores in the inner lining of stomach and upper portion of small intestine. Ranitidine helps to reduce excessive acid production in patient's stomach. Increasing prevalence of risk factors to cause peptide ulcers in patients such as use of pain relievers, use of certain medications (steroids, low-dose aspirin, combination of selective serotonin reuptake inhibitors (SSRIs) with pain relievers), smoking, excessive alcohol consumption, untreated stress and easting of spicy foods; greatly increases the chance of developing ulcers.

Market Dynamics

Ranitidine market is expected to witness growth during the forecast period, owing to growing prevalence of gastroesophageal reflux disease (GERD) and stomach and intestinal ulcers, worldwide. For instance, a review study published in the Gut Journal in June 2014, estimated the range of GERD prevalence in global population, in 2014. This study reported GERD prevalence as 18%- 28% in North America, 9%-26% in Europe, 3%-8% in East Asia, 9%-33% in Middle East, 12% in Australia, and 23% in Latin America. According to this statistics, North America and Middle East are at higher risk to develop GERD disease.

Furthermore, higher efficacy and tolerability of ranitidine in suppression of stomach & intestinal ulcers is increasing the adoption of ranitidine-based medication in the market.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches and approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global ranitidine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies and future plans
Key companies covered as a part of this study include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Strides Pharma Science Limited (Strides Shasun), Tocris Bioscience (R&D Systems), Merck KGaA, and Sun Pharmaceutical Industries Limited among others.
Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global ranitidine market report caters to various stakeholders in this industry including investors, suppliers, ranitidine-based product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the ranitidine market.

Market Segmentation

By Strength (Revenue, USD Mn, 2021-2033)
- 75 mg
- 150 mg
- 300 mg
By Form (Revenue, USD Mn, 2021-2033)
- Tablets
- Syrup
- Injection
By Route of Administration (Revenue, USD Mn, 2021-2033)
- Oral
- Intravenous
By Application (Revenue, USD Mn, 2021-2033)
- Intestinal & Stomach Ulcers
- Gastroesophageal Reflux Disease (GERD)
- Esophagitis
- Zollinger-Ellison Syndrome
- Others
By Distribution Channel (Revenue, USD Mn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Ranitidine Market, By Region: (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- GlaxoSmithKline plc
- Boehringer Ingelheim GmbH
- Strides Pharma Science Limited (StridesShasun)
- Tocris Bioscience (R & D Systems)
- Merck KGaA
- Sun Pharmaceutical Industries Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Strength
- Market Snapshot, By Form
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Ranitidine Market, By Strength, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
75 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
150 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
300 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Ranitidine Market, By Form, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Syrup
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Ranitidine Market, By Route of Administration, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Ranitidine Market, By Application, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Intestinal & Stomach Ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Gastroesophageal Reflux Disease (GERD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Esophagitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Zollinger-Ellison Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Ranitidine Market, By Distribution Channel, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Ranitidine Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- GlaxoSmithKline plc
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Boehringer Ingelheim GmbH
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Strides Pharma Science Limited (StridesShasun)
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Tocris Bioscience (R & D Systems)
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Sun Pharmaceutical Industries Limited
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
  - Analyst Views

11. Section

References
Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

雷尼替丁市場：依活性成分濃度、劑型、給藥途徑、應用、通路及地區分類

Ranitidine Market, By Strength, By Form, By Route of Administration, By Application, By Distribution Channel, By Geography

市場動態

本次調查的主要特點

目錄

第1章：研究目標與前提條件

第2章市場展望

第3章：市場動態、監管與趨勢分析

第4章全球雷尼替丁市場：依濃度分類，2021-2033年

第5章全球雷尼替丁市場：依劑型分類，2021-2033年

第6章全球雷尼替丁市場：依給藥途徑分類，2021-2033年

第7章全球雷尼替丁市場：依應用領域分類，2021-2033年

第8章全球雷尼替丁市場：依通路分類，2021-2033年

第9章全球雷尼替丁市場：依地區分類，2021-2033年

第10章競爭格局

第11章

Market Dynamics

Key features of the study

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Ranitidine Market, By Strength, 2021 - 2033, (USD Mn)

5. Global Ranitidine Market, By Form, 2021 - 2033, (USD Mn)

6. Global Ranitidine Market, By Route of Administration, 2021 - 2033, (USD Mn)

7. Global Ranitidine Market, By Application, 2021 - 2033, (USD Mn)

8. Global Ranitidine Market, By Distribution Channel, 2021 - 2033, (USD Mn)

9. Global Ranitidine Market, By Region, 2021 - 2033, (USD Mn)

10. Competitive Landscape

11. Section

雷尼替丁市場：依活性成分濃度、劑型、給藥途徑、應用、通路及地區分類

Ranitidine Market, By Strength, By Form, By Route of Administration, By Application, By Distribution Channel, By Geography

市場動態

本次調查的主要特點

目錄

第1章：研究目標與前提條件

第2章 市場展望

第3章：市場動態、監管與趨勢分析

第4章 全球雷尼替丁市場：依濃度分類，2021-2033年

第5章 全球雷尼替丁市場：依劑型分類，2021-2033年

第6章 全球雷尼替丁市場：依給藥途徑分類，2021-2033年

第7章 全球雷尼替丁市場：依應用領域分類，2021-2033年

第8章 全球雷尼替丁市場：依通路分類，2021-2033年

第9章 全球雷尼替丁市場：依地區分類，2021-2033年

第10章 競爭格局

第11章

Market Dynamics

Key features of the study

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Ranitidine Market, By Strength, 2021 - 2033, (USD Mn)

5. Global Ranitidine Market, By Form, 2021 - 2033, (USD Mn)

6. Global Ranitidine Market, By Route of Administration, 2021 - 2033, (USD Mn)

7. Global Ranitidine Market, By Application, 2021 - 2033, (USD Mn)

8. Global Ranitidine Market, By Distribution Channel, 2021 - 2033, (USD Mn)

9. Global Ranitidine Market, By Region, 2021 - 2033, (USD Mn)

10. Competitive Landscape

11. Section

第2章市場展望

第4章全球雷尼替丁市場：依濃度分類，2021-2033年

第5章全球雷尼替丁市場：依劑型分類，2021-2033年

第6章全球雷尼替丁市場：依給藥途徑分類，2021-2033年

第7章全球雷尼替丁市場：依應用領域分類，2021-2033年

第8章全球雷尼替丁市場：依通路分類，2021-2033年

第9章全球雷尼替丁市場：依地區分類，2021-2033年

第10章競爭格局